Trump’s Efforts to Bring Pharma Manufacturing Back to the U.S. Hindered by Uncertainty

Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’

Navigating Uncertainty in U.S. Pharmaceutical Manufacturing Regulations Recent market analysis indicates a significant cloud of uncertainty surrounding the regulations introduced by former President Donald Trump aimed at enhancing pharmaceutical manufacturing domestically. Despite several executive orders … Read more